Fundraising FoxBiothea Pharma
Boston, US · Delaware corporation
Find your way into Biothea Pharma
Sign up to see every warm intro you have to Biothea Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biothea Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biothea Pharma develops a needle-free treatment for severe allergic reactions and anaphylaxis, intended as a convenient, lower-cost alternative to existing products. It operates in the pharmaceutical/biotech industry focused on allergic emergency care.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$22M disclosed across 1 round · 2021
▶$22MraisedAug 2021 · 30 investors · BiotechnologyRule 506(b)
▶$22MraisedAug 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Torbjorn BjerkeDirector
- Marina S. BozilenkoExecutive Officer, Director
- Anthony AiudiDirector
- Andrea J. CorcoranExecutive Officer
- Jean-Pierre Sommadossi, Ph.D.Director
- Rohit MehtaExecutive Officer
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
AltaThera PharmaceuticalsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Tarsus PharmaceuticalsTarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions. Its treatment areas include Demodex blepharitis, and it works closely with eye care professionals and patients.
GlobaldataGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies working in the same space as Biothea Pharma.
Frequently asked questions
- What does Biothea Pharma do?
- Biothea Pharma develops a needle-free treatment for severe allergic reactions and anaphylaxis, intended as a convenient, lower-cost alternative to existing products. It operates in the pharmaceutical/biotech industry focused on allergic emergency care.
- How much funding has Biothea Pharma raised?
- Biothea Pharma has disclosed $22M raised across 1 round.
- Where is Biothea Pharma headquartered?
- Biothea Pharma is headquartered in Boston, US.